MultiCorp International Inc (MCIC)

[MoneyMakesMoney]

I am looking for clarification

Hi all,
I have been following this stock for a couple weeks. I have been trying to read as much as I can. I can only make 3 posts per day as of now... so for my first post...

I just tried to search the board for my answer but apparently I cant search the board unless I am a premium member.

If anyone could help me out I am trying to research why when I at the chart for XMDC on September 2007, XMDC is way up and then begins to trickle down to sub penny?

Apparently XMDC has traded at least a couple different names such as "Summus Works, Inc."

Please refer to this thread that I have found.

http://www.allstocks.com/stockmessageboard/cgi-bin/ultimatebb.cgi?ubb=get_topic;f=8;t=028293;p=2

In this thread, under post by 'OldGuy' it states,
"You aren't serious about htis are you? They have had three r/s, the latest was one of the worst I have ever seen. Here is part of their track record. They exist to get your money.

Formerly Summus Works, Inc. until 9/07 Formerly Prime Rate Investors, Inc. until 2/06

Formerly Mountain Gensing, Inc. until 06/02

You had better take heed. This company is out to say whatever they have to to get your money. Like so many, they use great sounding p/r's to get into your wallet. They will not deliver. You will
lose!"

This has caught my eye because prior to the post by 'OldGuy' there is a post by 'eddy' stating,


"the pr. yesterday-------------------Press Release Source: XTend Medical Corporation


XTend Medical (XMDC) Penetrates $118 Million European Telemedicine Market
Tuesday July 22, 5:31 am ET


Company Begins Telemedicine Program With U.K. University


SUN VALLEY, CA--(MARKET WIRE)--Jul 22, 2008 -- XTend Medical Corporation (Other OTC:XMDC.PK - News), a company that delivers cutting-edge telemedicine solutions to the healthcare industry, announced today the company will begin a telemedicine program in Europe to track the remote monitoring of diabetic patients in early August. According to Frost and Sullivan the European market is expected to hit $236 Million by 2014.
ADVERTISEMENT


The company released the following statement: "Our presence here in the U.S. has attracted many companies from Europe that are interested on our telehealth programs. While many companies offer a similar solution, the fact that XTend's solution was chosen over these is critical in the fact that our solutions are widely accepted as being the easiest to implement and maintain. This is a major accomplishment as our marketing efforts in educating the medical community as to the ease with which our system can be integrated into their practice has proven once again to stand above our competitor's solutions. By having a presence in Europe, this will assist the company as we grow our brand globally over the next three years and on. We'll release further information regarding our European program as the results are monitored through the University that has asked us to maintain their privacy for now," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

For any healthcare agency or physician group that would like to find out more about how XTend can assist in your management of diabetic patients, please visit the company website at www.xtendmedical.com or email us at info*xtendmedical.com

About XTend Medical: XTend Medical Corporation markets and sells telehealth and telemedicine solutions for monitoring and caring for patients with chronic disease conditions. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at www.xtendmedical.com.

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.


Contact:
Company Contact:
FutureTechIR for XTend Medical Corporation
Investor Relations
[phone]"

There is posters mentioning of contracts, the charts looking amazing, etc.


I understand they did an R/S and I believe at that time their new hot product at the time was more relevant to diabetes (I think I remember seeing an email posted by someone earlier today asking about it).

Any information would be greatly appreciated. This is absolutely not a bash post, I am just looking for information and clarification.

Thank You
MoneyMakesMoney